VirionHealth receives $4.2 m from DARPA
VirionHealth, a new biotechnology company developing novel therapeutics for respiratory viral infections, announced it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA)